Letters to the Editor: Letter to the Editor regarding ‘A challenge to the dopamine orthodoxy in schizophrenia’

Abstract

Get full access to this article

View all access options for this article.

References

Gwilt

González

Olliffe

, et al. (2020) Actions of trace amines in the brain-gut-microbiome axis via trace amine-associated receptor-1 (TAAR1). Cellular and Molecular Neurobiology 40: 191–201.

Hunt

Large

Cleary

, et al. (2018) Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990-2017: Systematic review and meta-analysis. Drug and Alcohol Dependence 191: 234–258.

Liu

(2018) TAAR1 in addiction: Looking beyond the tip of the iceberg. Frontiers in Pharmacology 9: 279.

Nair

Miners

McKinnon

, et al. (2022) Binding of SEP-363856 within TAAR1 and the 5HT1A receptor: Implications for the design of novel antipsychotic drugs. Molecular Psychiatry 27: 88–94.

Norman

Olver

(2023) A challenge to the dopamine orthodoxy in schizophrenia? Australian and New Zealand Journal of Psychiatry 57: 1397.